Rare Disease research & cures
Drug pricing, gene therapy, and rare disease funding generally;
H.R. 4393 - Advancing Access to Precision Medicine;
H.R. 2507/S. 2158 Newborn Screening Saves Lives Reauthorization Act;
H.R. 8045 - Genome Editing Threat Assessment Act;
HR 2501 - Medical Nutrition Equity Act;
MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BURRELL INTERNATIONAL GROUP LLC
410 First Street, SE, Suite 300, Washington, DC, 20003, US
DEBORAH LYNN BURRELL